Releases › HCPCS Level II October 2023
HCPCS Level II October 2023
Effective 2023-10-01 to 2023-12-31. 7,941 codes in the release.
47added
4revised
2removed
Codes added 47
| Code | Description |
|---|---|
| A2022 | Innovaburn or innovamatrix xl, per square centimeter |
| A2023 | Innovamatrix pd, 1 mg |
| A2024 | Resolve matrix, per square centimeter |
| A2025 | Miro3d, per cubic centimeter |
| A9156 | Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml |
| A9268 | Programmer for transient, orally ingested capsule |
| A9269 | Programable, transient, orally ingested capsule, for use with external programmer, per month |
| A9292 | Prescription digital visual therapy, software-only, fda cleared, per course of treatment |
| A9573 | Injection, gadopiclenol, 1 ml |
| A9603 | Injection, pafolacianine, 0.1 mg |
| A9697 | Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose |
| B4148 | Enteral feeding supply kit; elastomeric control fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape |
| C9152 | Injection, aripiprazole, (abilify asimtufii), 1 mg |
| C9153 | Injection, amisulpride, 1 mg |
| C9154 | Injection, buprenorphine extended-release (brixadi), 1 mg |
| C9155 | Injection, epcoritamab-bysp, 0.16 mg |
| C9156 | Flotufolastat f 18, diagnostic, 1 millicurie |
| C9157 | Injection, tofersen, 1 mg |
| C9158 | Injection, risperidone, (uzedy), 1 mg |
| C9788 | Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination |
| C9789 | Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed |
| C9790 | Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance |
| C9791 | Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent |
| C9792 | Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study) |
| E0490 | Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote |
| E0491 | Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply |
| H2040 | Coordinated specialty care, team-based, for first episode psychosis, per month |
| H2041 | Coordinated specialty care, team-based, for first episode psychosis, per encounter |
| J0349 | Injection, rezafungin, 1 mg |
| J0801 | Injection, corticotropin (acthar gel), up to 40 units |
| J0802 | Injection, corticotropin (ani), up to 40 units |
| J0874 | Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg |
| J0889 | Daprodustat, oral, 1 mg, (for esrd on dialysis) |
| J2359 | Injection, olanzapine, 0.5 mg |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg |
| J7214 | Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. |
| J7353 | Anacaulase-bcdb, 8.8% gel, 1 gram |
| J7519 | Injection, mycophenolate mofetil, 10 mg |
| J9051 | Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg |
| J9064 | Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg |
| J9345 | Injection, retifanlimab-dlwr, 1 mg |
| K1036 | Supplies and accessories (e.g., transducer) for low frequency ultrasonic diathermy treatment device, per month |
| L1681 | Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion, extension, abduction control of hip joint, postoperative hip abduction type, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
| L5991 | Addition to lower extremity prostheses, osseointegrated external prosthetic connector |
| Q4285 | Nudyn dl or nudyn dl mesh, per square centimeter |
| Q4286 | Nudyn sl or nudyn slw, per square centimeter |
| V2526 | Contact lens, hydrophilic, with blue-violet filter, per lens |
Descriptions revised 4
| Code | Was, and is now |
|---|---|
| A4344 | |
| J1921 | |
| K1004 | |
| K1028 |
Terminated 2
| Code | Description |
|---|---|
| C9151 | Injection, pegcetacoplan, 1 mg |
| J0800 | Injection, corticotropin, up to 40 units |